Acusphere, Inc.Lexington, MA United States
Company Description
Acusphere micromanages its products, but then how else would you handle microparticles? The company uses a proprietary technology to create porous microparticles smaller than red blood cells to develop cardiovascular drugs for the detection of coronary artery disease. The company's primary candidate, Imagify, is an injectable drug designed to identify coronary artery disease. The company is completely focused on getting Imagify to market in the US and Europe. Acusphere believes it can successfully market Imagify to echocardiologists (a subset of cardiologists) by touting its ability to improve ultrasound detection of coronary artery disease.
| 99 Hayden Avenue, Suite 385 | Phone: 617-648-8800 | |
| Lexington, MA 02421 | Fax: 978-863-9993 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Acusphere, Inc. Rankings
Executives
| 9 executives listed for Acusphere, Inc.'s Lexington, MA location. | ||
| Chairman and President | Sherri Oberg | |
|---|---|---|
| SVP Regulatory Affairs and Operations | Michael Slater | |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Acusphere, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
